Editor’s Note: This article has been edited since it’s original publication.
Rowan hosted its annual “Faculty Research Day” on March 29 to celebrate Rowan’s accomplishments in research and collaboration opportunities for faculty and all attending.
The event showcased faculty research, an awards presentation and a keynote address from James M. Golubieski, president of New Jersey Health Foundation (NJHF), Inc.
Starting at 9 a.m, various speakers took the stage to address the crowd. Ali Houshmand, president of the university, spoke about how far Rowan has come in terms of research. In addition, Houshmand recounted that over 10 years ago Rowan had less than $10 million invested in research, but now; Rowan has a record high of $63 million invested in research.
“That’s really our goal to rebuild one [university] that represents the entirety of South Jersey,” Houshmand said.
After Houshmand’s introduction, Golubieski took the stand to talk about the foundation and opportunities they provide at NJHF which include research, finding solutions to stimulate economic development and growing science-based businesses. Afterward, he discussed the importance of Rowan’s partnership with them.
NJHF is partnered not only with Rowan but also Rutgers, Princeton and the New Jersey Institute of Technology (NJIT). Along with partnering with various colleges, they have recently partnered with Cooper University Health Care and Hackensack Meridian Health.
NJHF has community health, social service, and education grants that offer up to $25,000 for projects that address health-related community, social, and education issues.
“We share the same objectives and that’s really the advancement of success. That’s really the goal of what we do. We share that with all the individuals. That’s we use the passion part of it. Passion’s a big part of it,” Golubieski said.
After the keynote address, faculty were able to present their research.
Ivy Lee, an assistant professor in the department of finance, studied why investors rely on indicator consistency.
More specifically, Lee looks at earning news, sales news and cash reviews. Lee explained that there is consistency among these indicators. Lee’s reasoning is when indicators are consistent, it suggests higher precision for both indicators.
“It’s important to understand how investors use information in valuing sales, cash flow, and other non-earnings indicators,” Lee said.
Research for Rowan-Virtua School of Osteopathic Medicine and Durin Technologies was presented a designed blood test that can detect the presence of Alzheimer’s disease-related pathology up to 10 years before symptoms are shown with a nearly 97% accuracy rate.
Lastly, the awards presentation took place and four awards were given out.
James Heinzen, history professor and director of the Hollybush Institute, won the Research Achievement Award. Heinzen was nominated by Melissa Klapper, a history professor at Rowan.
The Breakthrough Research Award went to the Wu Lab Research team led by Chun Wu, associate professor of biological and biomedical sciences. They were nominated by members of the Wu Lab Research team and Vojislave Pophristic, dean of the College of Science & Mathematics and chemistry and biochemistry professor.
The award for excellence in graduate research was given to Giuseppina Carannante, a doctoral candidate for electrical & computer engineering. She was nominated by Nidhal C, Bouaynaya, associate dean for research & graduate studies and electrical & computer engineering professor.
The award for excellence in undergraduate research was given to Crystal Stackhouse, a dual major in physics and biomedical engineering. Stackhouse was nominated by Nathaniel Nucci, associate professor in physics & astronomy, and Mary Staehle, associate professor and interim department head for biomedical engineering.
The event ended with a research showcase and concurrent breakout sessions at 1 p.m.
For comments/questions about this story tweet @TheWhitOnline or email thewhit.newseditor@gmail.com
